{"schema_version":1,"citation_url":"https://567business.com/news/oura-counsel-health-625-million-ipo","title":"Oura shelved a $2.2 billion IPO. Six weeks later it is paying $625 million for a 70-person AI doctor startup","description":"The smart ring maker is buying Counsel Health in an all-cash deal, about 17 times what the startup raised, after posting 153% quarterly revenue growth.","author":"Patrick Karsh","publisher":"567 Business","date_published":"2026-11-11T00:07:28.185095Z","date_modified":"2026-11-11T00:07:59.321447Z","body_markdown":"Oura is paying $625 million in cash for Counsel Health, a young AI-powered doctor service. The deal comes six weeks after the smart ring maker shelved an initial public offering that aimed to raise up to $2.2 billion. Oura announced the deal on Tuesday and said it expects it to close before the end of the year, [according to the companies' press release](https://www.counselhealth.com/newsroom/oura-to-acquire-counsel-health-advancing-vision-for-more-connected-personalized-healthcare). The deal pays a large premium for a small company. Counsel has about 70 employees, Bloomberg reported, [according to TechCrunch](https://techcrunch.com/2026/11/10/oura-to-acquire-ai-native-primary-care-startup-counsel-health-for-625m/).\n\nThe bet is simple. Oura's ring tells people what is happening in their bodies, and Counsel is meant to let them act on it, with prescriptions, lab tests and referrals inside the Oura app.\n\n## The price tag, in numbers\n\nThe price is high compared with what Counsel raised. Counsel raised a $25 million Series A a year ago, led by Andreessen Horowitz and GV, and PitchBook estimates it raised about $36 million in total, TechCrunch reported. At $625 million, Oura is paying about 17 times the money investors put in. That works out to roughly $8.9 million per employee.\n\nThe table below lists the main figures. Oura's quarterly and annual results are preliminary and unaudited, the company said.\n\n| Item | Figure |\n| --- | ---: |\n| Purchase price (cash) | $625 million |\n| Counsel funding raised (PitchBook est.) | $36 million |\n| Counsel employees (Bloomberg) | About 70 |\n| Oura revenue, quarter to Sept. 30 | $533 million |\n| Oura revenue, fiscal 2026 | About $1.75 billion |\n| Oura adjusted EBITDA, quarter | $87 million |\n\nOura can afford it. Its revenue for the quarter ended September 30 rose 153% from a year earlier, and full-year revenue grew 92%, according to the release. Adjusted EBITDA was a 16% margin. Executive chairman David Shuman said that growth and more than six million members gave Oura \"the confidence to invest $625 million cash.\"\n\n## From IPO retreat to buying spree\n\nSix weeks ago, Oura was heading for the stock market. It formally launched IPO plans on September 21 and planned to raise up to $2.2 billion by selling 50 million shares, [CNBC reported](https://www.cnbc.com/2026/09/29/smart-ring-maker-oura-postpones-ipo-due-to-market-uncertainty.html). Eight days later, on September 29, it postponed the listing, citing \"uncertainty\" in the IPO market despite \"strong demand.\"\n\n\"We have the luxury of choosing our moment,\" CEO Tom Hale said then. The offering was aiming for a $15.6 billion valuation, [Fierce Healthcare reported](https://www.fiercehealthcare.com/digital-health/oura-acquire-ai-virtual-primary-care-partner-counsel-health-625m). Oura was valued at $11 billion after a $900 million funding round in October 2025, according to TechCrunch.\n\nSo instead of raising money from public investors, Oura is now spending its own. The IPO market has been rough for other big names, too. Anthropic is [asking public investors for a $1.4 trillion valuation](/news/anthropic-ipo-valuation-selloff) in a shaky market.\n\n## What Counsel actually does\n\nCounsel pairs a medical chatbot with its own staff of board-certified doctors. Users start by chatting with the AI, which draws on medical records, past conversations, clinical guidelines and, for Oura members, ring data. At any point, a patient can bring in a Counsel physician, who can diagnose, prescribe and refer, the release says.\n\nThe two companies are not strangers. Counsel's service was built into the Oura app in June, TechCrunch reported. In September they announced closer work on a Medicare program called ACCESS, which is set to begin early next year, according to Fierce Healthcare.\n\nCounsel will keep selling to health plans, health systems and employers, and its partners will not need Oura rings, [Counsel said in a separate post](https://www.counselhealth.com/resources/reimagining-primary-care-with-oura). Founder and CEO Muthu Alagappan will join Oura as chief clinical AI officer, TechCrunch reported.\n\n## The catch\n\nThere are real limits. Oura's own release says the Oura Ring \"is not a medical device\" and is not meant to diagnose or treat any condition. Counsel's doctors will be looking at data from a device that Oura itself says is not a medical device. The companies cite early results: more than 90% of surveyed Counsel users said their Oura data helped them get better care, and patients who saw a Counsel doctor rated the experience 4.6 out of 5. Those are the companies' own survey figures, not independent studies.\n\nSome ring owners were unsure at first. When the Counsel feature appeared in the app months ago, one user on [r/ouraring](https://www.reddit.com/r/ouraring/comments/1uax766/counsel_health_ai_integration/) wrote that it was \"a little annoying to pay so much for something explicitly still in beta.\"\n\nOura also faces more competition. Rival ring makers such as RingConn and Ultrahuman are pushing into its market, TechCrunch noted.\n\n## How the news landed on X\n\nBloomberg's Mark Gurman was among the first to post the deal and tied it directly to Oura's scrapped IPO.\n\nhttps://x.com/markgurman/status/2120212011233792024\n\nCounsel Health announced the sale on its own account, saying it was founded three years ago to rethink primary care with AI.\n\nhttps://x.com/CounselHealth/status/2120203670063284623\n\nHims House, an account that follows telehealth company Hims & Hers, said the deal makes Hims's competitive landscape tougher. That is the wider stakes. A wearable company with millions of paying members now wants to be a doctor's office, too.\n\nhttps://x.com/himshouse/status/2120232993700954328\n\nFor other hardware and health startups, the message is mixed. Venture investors are still [paying up for hardware companies](/news/path-robotics-nominal-hardware-startups-raise). But Oura's choice shows that even a fast-growing, profitable startup may find buying another company easier right now than going public.","link_base":"https://567business.com/news/oura-counsel-health-625-million-ipo","citation_guidance":"Cite citation_url. Preserve source links, dates and qualifications. date_modified is an edit date, not proof that every claim was rechecked. Third-party images and quoted material retain their own rights."}